Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Alzheimer Type”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06377033
What this trial is testing

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Who this might be right for
Genetic PredispositionParagangliomaPheochromocytoma+7 more
University of Pennsylvania 1,000
Testing effectiveness (Phase 2)Study completedNCT00515333
What this trial is testing

TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
TauRx Therapeutics Ltd 323
Not applicableEnrolling By InvitationNCT07595666
What this trial is testing

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Who this might be right for
DementiaMovement DisordersALS - Amyotrophic Lateral Sclerosis+11 more
prof. dr. Koen Van Laere 1,600
Not applicableStudy completedNCT05350514
What this trial is testing

Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetes, Youth Onset
University of Colorado, Denver 14
Post-approval studies (Phase 4)WithdrawnNCT00711204
What this trial is testing

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Who this might be right for
Severe Alzheimer's Disease
Eisai Inc.
Not applicableUnknownNCT02835716
What this trial is testing

Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO

Who this might be right for
Alzheimer Disease
Millennium Magnetic Technologies, LLC 150
Large-scale testing (Phase 3)Ended earlyNCT04408755
What this trial is testing

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 184
Not applicableEnded earlyNCT00978536
What this trial is testing

A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).

Who this might be right for
Disseminated Sclerosis
Nantes University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT03875638
What this trial is testing

Treating Hyperexcitability in AD With Levetiracetam

Who this might be right for
Alzheimer DementiaAlzheimer DiseaseDementia of Alzheimer Type+1 more
Beth Israel Deaconess Medical Center 58
Testing effectiveness (Phase 2)Study completedNCT04566770
What this trial is testing

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Who this might be right for
COVID-19
CanSino Biologics Inc. 480
Large-scale testing (Phase 3)Study completedNCT05894954
What this trial is testing

Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentDementia, Mild
Alzheimer's Prevention and Reversal Project, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT02434666
What this trial is testing

Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07

Who this might be right for
Dementia of the Alzheimer's Type
Chase Pharmaceuticals Corporation, an affiliate of Allergan plc 21
Not applicableUnknownNCT05232526
What this trial is testing

Imagery in Early Stages of Dementia

Who this might be right for
Mental ImageryDementia of Alzheimer Type
University of West Attica 105
Large-scale testing (Phase 3)Study completedNCT04797715
What this trial is testing

Assessing Clinical Outcomes in Alzheimer's Disease Agitation

Who this might be right for
Agitation in Patients With Dementia of the Alzheimer's TypeAlzheimer DiseaseAgitation,Psychomotor
Axsome Therapeutics, Inc. 178
Testing effectiveness (Phase 2)Looking for participantsNCT06597942
What this trial is testing

Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

Who this might be right for
Alzheimer&Amp;Amp;#39;s DiseaseAlzheimer DiseaseDementia Alzheimer Type+4 more
University of California, Los Angeles 54
Large-scale testing (Phase 3)Ended earlyNCT00857649
What this trial is testing

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 369
Not applicableLooking for participantsNCT06339190
What this trial is testing

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Who this might be right for
Neurodegenerative DiseasesDementia
Monash University 1,000
Not applicableLooking for participantsNCT05885295
What this trial is testing

The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)

Who this might be right for
StrokeStroke (CVA) or TIADementia, Vascular+3 more
Imperial College London 700
Not applicableWithdrawnNCT04942184
What this trial is testing

STRATEGIES to Improve Memory in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, MildMild Cognitive Impairment
Boston University
Large-scale testing (Phase 3)Ended earlyNCT02248116
What this trial is testing

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 198
Next Page